Accelerate to discover
Related topics
Synthesis and characterization of functional nanofilm-coated live Immune cells using CQ1
Apr 10, 2019
Layer-by-layer assembly techniques have been extensively studied in cell biology because of their simplicity of...
Product update: The high pass plus cassette
Apr 9, 2019
The high pass plus gel cassette is the newest addition to the Pippin family. It is dedicated to the BluePippin...
Comprehending diseased cardiac mechanics using speckle tracking echocardiography
Apr 4, 2019
Are you working with high ultrasound imaging and are you interesting in speckle tracking echocardiography (STE)? Watch...
Novel imaging-based assay for hERG channel inhibition using iPS-derived Cardiomyocytes
Apr 4, 2019
A large percentage of drugs fail in clinical studies due to cardiac toxicity, such as drug-induced QT...
Modified Beta-carotene-bound albumin nanoparticles for breast tumor ablation
Mar 29, 2019
The albumin nanoparticles were fabricated using a beta-carotene cross-linker via the Nab technique. These new albumin...
Spectral flow cytometric analysis of loss-of-function mutations in granular cell tumors
Mar 29, 2019
Granular cell tumors (GCTs) are rare tumors that can arise in multiple anatomical locations,and are characterized by...
IncuCyte white paper: live-cell analysis for Neuroscientists
Mar 20, 2019
Stem cell technologies using iPSCs allow researchers to create differentiated neurons and support cells to study human...
Cell plasticity associated to circulating tumor cells from prostate cancer patients
Mar 13, 2019
Treatment resistance is associated with tumor cells molecular plasticity. In metastatic castration resistant prostate...
Aug 7, 2018
LSD1 is a flavin adenine dinucleotide (FAD)-dependent homolog of the amine oxidase family and there was recently brought attention to it as a potential therapeutic target. The interest came from an observation of unusually high expression of LSD1 in certain types of poor-prognosis cancers. It was previously thought that LSD1 removes monomethyl and dymethyl histone marks. However, recently it was showed that it interacts with multiple transcripton factor. This raised a possibility of other drugs being used.
New inhibitor ORY-1001 was succesfully tested on LSD1 and blast cell differentioation was observed. The flow cytometric testing on this experiment was done with Novocyte. ORY-1001 disrupts the protein interaction between LSD1 and GFI1.
Related technologies: Conventional flow cytometry
Get more info
Brand profile
ACEA manufactures xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
More info at:
www.aceabio.com
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
